Within3, the leading Launch Intelligence platform for life sciences, has appointed Erin Mistry as Chief Executive Officer. Mistry brings more than 20 years of experience in global biopharma commercialization, having launched and priced more than 20 pharmaceutical products across eight therapeutic areas. Most recently, she served as Chief Commercial Officer at CorMedix, where she led the launch of DefenCath and drove the company to break-even within six months and profitability in under a year. As CEO, Mistry will drive the expansion of Within3's Launch Intelligence platform and services, helping pharmaceutical teams unify fragmented data, anticipate market shifts, and act with confidence at every stage of launch.
CorMedix IncMistry's prior success at CorMedix (leading DefenCath launch to profitability) is highlighted, reflecting positively on her leadership and CorMedix's past performance.
AstraZeneca PLCAppointment of experienced CEO to drive expansion of Within3's platform.